MedPath

PET study using [11C]K-2 on the relationship between AMPA receptor and tau accumulation in Alzheimer's disease and related diseases

Not Applicable
Recruiting
Conditions
Alzheimer&#39
s disease,Mild cognitive impairment(MCI)
Registration Number
JPRN-UMIN000046956
Lead Sponsor
Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Patients diagnosed with MCI or AD 1) Patients with a history of or complications from organic brain disease (disorders of consciousness, head trauma requiring hospitalization, obvious cerebral infarction or cerebral hemorrhage, etc.) (2) Those who have substance-related disorders (e.g., drug dependence). (3) Those who have complications from serious diseases, or those who have a history of such complications and are judged by the physician as the researcher to be inappropriate for this research. (4) Those with pacemakers or internal metal devices (brain clips, bolts, etc.) (5) Those with tattoos (including tattoos and art makeup) (6) Those who are highly claustrophobic (7) Patients who are pregnant or may be pregnant, and those who are breastfeeding (8) Others who are judged inappropriate as research subjects by the researcher's physician. Healthy volunteer group 1) Subjects with a history of or complications from organic brain disease (disorders of consciousness, head trauma requiring hospitalization, obvious cerebral infarction or cerebral hemorrhage, etc.) (2) Those who have substance-related disorders (e.g., drug dependence). (3) Those who have complications from serious diseases, or those who have a history of such complications and are judged by the physician as the researcher to be inappropriate for this research. (4) Those with pacemakers or internal metal devices (brain clips, bolts, etc.) (5) Those with tattoos (including tattoos and art makeup) (6) Those who are highly claustrophobic (7) Patients who are pregnant or may be pregnant, and those who are breastfeeding (8) Subjects who are judged inappropriate as research subjects by the researcher's physician.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quantitative evaluation of the distribution of [11C]K-2
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath